JEFF EVANS
Impact in
- Immunology and Allergy top 1%
- Cell Adhesion Molecules Research
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
- Oncology 8
- Peptidase Inhibition and Analysis 2
- CAR-T cell therapy research 1
-
- Hepatocellular Carcinoma Treatment and Prognosis 3
- Co-authors
- Margaret C. Frame (1 shared paper)Gordon W. McLean (1 shared paper)Egle Avizienyte (1 shared paper)Neil O. Carragher (1 shared paper)Valerie G. Brunton (1 shared paper)John F. Marshall (1 shared paper)Jacqueline A. Hall (1 shared paper)Rob Jones (1 shared paper)
- Journals
- Annals of Oncology (6 papers)Nature Reviews Clinical Oncology (1 paper)Journal of Clinical Medicine (1 paper)British journal of surgery (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
JEFF EVANS
14 papers receiving 1.3k citations
JEFF EVANS's Hit Papers
Peers
Comparison fields: 5 of 97
- Immunology and Allergy 401
- Cancer Research 239
- Cell Biology 245
- Oncology 342
- Hepatology 84
Countries citing papers authored by JEFF EVANS
This map shows the geographic impact of JEFF EVANS's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by JEFF EVANS with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites JEFF EVANS more than expected).
Fields of papers citing papers by JEFF EVANS
This network shows the impact of papers produced by JEFF EVANS. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by JEFF EVANS. The network helps show where JEFF EVANS may publish in the future.
Co-authors
The 25 scholars most cited alongside JEFF EVANS, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The role of focal-adhesion kinase in cancer — a new therapeutic opportunity Hit paper breakdown → | 2005 | 883 |
| 2 | 2018 | 266 | |
| 3 | 2016 | 75 | |
| 4 | 2019 | 21 | |
| 5 | 2021 | 13 | |
| 6 | 2019 | 4 | |
| 7 | 2020 | 2 | |
| 8 | 2014 | 2 | |
| 9 | 2022 | 2 | |
| 10 | 2024 | 1 | |
| 11 | A Phase I study of IMCgp100: durable responses with a novel first-in-class immunotherapy for advanced melanoma | 2014 | 1 |
| 12 | 2019 | 1 | |
| 13 | 2015 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2002 | 1 |
About JEFF EVANS
JEFF EVANS is a scholar working on Oncology, Hepatology, Genetics, Cancer Research and Pulmonary and Respiratory Medicine, having authored 15 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Peptidase Inhibition and Analysis (2 papers), Cancer Genomics and Diagnostics (1 paper), Cancer Research and Treatments (1 paper), CAR-T cell therapy research (1 paper), Vascular Anomalies and Treatments (1 paper), NF-κB Signaling Pathways (1 paper) and Toxin Mechanisms and Immunotoxins (1 paper). The work is most often cited by research in Immunology and Allergy (401 citations), Cancer Research (239 citations), Cell Biology (245 citations), Oncology (342 citations) and Hepatology (84 citations). JEFF EVANS has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Margaret C. Frame, Gordon W. McLean, Egle Avizienyte, Neil O. Carragher, Valerie G. Brunton, John F. Marshall, Jacqueline A. Hall, Rob Jones, Mark T. Sullivan and Robin L. Anderson. Their work appears in journals such as Annals of Oncology, Nature Reviews Clinical Oncology, Journal of Clinical Medicine, British journal of surgery and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.